The influence of smoking and of oral and transdermal nicotine on blood pressure, and haematology and coagulation indices

Thrombosis and Haemostasis

Volumn 78, Issue 3, 1997, Pages 1093-1096

  Blann, Andrew D ^a   Steele, Christopher ^b   McCollum, Charles N ^c  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b The Practice   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; FIBRINOGEN; HEMOGLOBIN; NICOTINE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGY; HUMAN; HUMAN EXPERIMENT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOSIS; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030868475     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657692     Document Type: Article

References (41)

1. Bartecchi CE, MacKenzie TD, Schrier RW. The human cost of tobacco use. New Engl J Med 1994; 330: 907-12.
2. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. Br Med J 1994; 309: 901-11.
3. Hansen EF, Andersen LT, von Eyben FE. Cigarette smoking and age at first acute myocardial infarction, and influence of gender and extent of smoking. Am J Cardiol 1993; 71: 1439-42.
4. Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. New Engl J Med 1965; 273: 775-9.
5. Bain C, Hennekens CH, Rosner B, Speizer FE, Jesse MJ. Cigarette consumption and deaths from coronary heart disease. Lancet 1978; i: 1087-8.
6. Krupski WC. The peripheral vascular consequences of smoking. Ann Vasc Surg 1991; 5: 291-304.
7. Powell JT. Smoking and arterial disease - News of the old enemy. Eur J Vasc Surg 1991; 5: 227-8.
8. Zalokar JB, Richard JL, Claude JR. Leukocyte count, smoking and myocardial infarction. New Engl J Med 1981; 304: 465-8.
9. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting and the risk of ischaemic heart disease. Lancet 1987; ii: 986-8.
10. Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haemat 1992; 14: 281-7.
11. Lowe GDO, Wood DA, Douglas JT, Riemersma RA, Macintyre CCA, Takase T, Tuddenham EGD, Forbes CD, Elton RA, Oliver MF. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991; 65: 339-43.
12. Allen RA, Kluft C, Brommer EJP. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985; 5: 443-50.
13. Belch JJF, McArdle BM, Burns P, Lowe GDO, Forbes CD. The effects of acute smoking on platelet behavior, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost 1984; 51: 6-8.
14. Blann AD, McCollum CN. Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993; 70: 707-11.
15. De Cesaris R, Ranieri G, Filitti V, Bonfantino MV, Andriani A. Cardiovascular effects of smoking. Cardiology 1992; 81: 233-7.
16. Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115: 242-9.
17. Wilhelmsen L. Smoking as a cardiovascular risk factor - new strategies for smoking cessation. Lewiston, NY: Hogrefe & Huber 1991.
18. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155: 1933-41.
19. Transdermal Nicotine Study group. Transdermal nicotine for smoking cessation. J Amer Med Assoc 1991; 266: 3133-8.
20. Tonnesen P, Norregaard J, Simonsen K, Sawe U. A double blind trial of a 16-hour transdermal nicotine patch in smoking cessation. New Engl J Med 1991; 325: 311-5.
21. Khosla S, Laddu A, Ehrenpreis S, Somberg JC. Cardiovascular effects of nicotine: Relation to deleterious effects of cigarette smoking. Am Heart J 1994; 127: 1669-72.
22. Henningfield JE. Nicotine medications for smoking cessation. New Engl J Med 1995; 333: 1196-203.
23. Benowitz NL. Smoking-induced coronary vasoconstriction: Implications for therapeutic use of nicotine. J Amer Coll Cardiol 1993; 22: 648-9.
24. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from non-smokers. Am J Public Health 1987; 77: 1435-8.
25. Feyerabend C, Russell MAH. A rapid gas-liquid chromatographic determination of cotinine in biological fluids. Analyst 1980; 105: 993-1001.
26. Zimmermann M, McGeachie J. The effect of nicotine on aortic endothelial cell turnover. Atherosclerosis 1985; 58: 39-47.
27. Blaes N, Piovella F, Samaden A, Boutherin-Falson O, Ricetti M, Nicotine alters fibronectin and factor VII/vWf in human vascular endothelial cells. Br J Haem 1986; 64: 675-87.
28. Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-11.
29. Calori G, D'Angelo A, Valle PD, Ruotolo G, Ferini-Strambi L, Giusti C, Errera A, Gallus G. The effect of cigarette smoking on cardiovascular risk factors: a study of monozygotic twins discordant for smoking. Thromb Haemost 1996; 75: 14-8.
30. Feher MD, Rampling MW, Brown J, Robinson R, Richmond W, Cholerton S, Bain BJ, Sever PS. Acute changes in atherogenic and thrombogenic factors with cessation of smoking. J Roy Soc Med 1990; 83: 146-8.
31. Thomas GAO, Davies SV, Rhodes J, Russell MAH, Feyerabend C, Sawe U. Is transdermal nicotine associated with cardiovascular risk? J Royal Coll Phys Lond 1995; 29: 392-6.
32. Dacosta A, Guy JM, Tardy B, Gonthier R, Denis L, Lamaud M, Cerisier A, Verneyre H. Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 1993; 14: 1709-11.
33. Sawe U, Maggiorelli F, Fornai E, Simonini P, Ferdeghini EM, Miccoli R, Testa R, Massetani R, Murri L, Paoletti P. Continuous and intermittent transdermal delivery of nicotine: Cardio-respiratory, metabolic effects and sleep patterns. J Smok Rel Dis 1995, 6: 25-33.
34. Nyberg G, Panfilov V, Sivertsson R, Wilhelmsen L. Cardiovascular effects of nicotine chewing gum in healthy non-smokers. Eur J Clin Pharmacol 1982; 23: 303-7.
35. Doussel JC, Gutierres JB, Dousset N. Hypercholesterolaemia after administration of nicotine chewing gum. Lancet 1986; ii: 1393.
36. Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982; 65: 465-9.
37. Smith JR, Landau SA. Smokers' polycythaemia. New Engl J Med 1978; 298: 6-10.
38. Blann AD, Seigneur M, Adams R, McCollum CN. Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur J Vasc Endovasc Surg 1996; 12: 218-22.
39. Smith FB, Lee AJ, Fowkes FGR, Rumley A, Lowe GDO. Smoking, haemostatic factors and the severity of aorto-iliac and femoro-popliteal disease. Thromb Haemost 1996; 75: 19-24.
40. Benowitz NL. Nicotine and coronary heart disease. Trends Cardiovasc Med 1991; 1: 315-21.
41. Working Group for the Study of Transdermal nicotine in patients with coronary artery disease. Nicotine-replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989-95.